发明名称 |
Muundatud vaktsiiniaviirus Ankara (MVA), sellega nakatatud peremeesrakk ning seda sisaldav farmatseutiline kompositsioon, MVA valmistamine ja raviotstarbeline kasutamine |
摘要 |
<p>The invention provides new strains of the Modified Vaccinia Virus Ankara (MVA) that have a strongly reduced virulence for most mammals, especially humans, but nevertheless grows in cells of a continuous cell line approved for the production of a therapeutic agent such as a vaccine. The invention also provides a method for producing said adapted MVA strains. The adapted MVA can be used e.g. for parenteral immunization, as a vector system, or in the active or inactivated from as an adjuvant or as a regulator of the unspecific components of the immune system.</p> |
申请公布号 |
EE05633(B1) |
申请公布日期 |
2013.02.15 |
申请号 |
EE20020000507 |
申请日期 |
2001.03.10 |
申请人 |
ANTON MAYR |
发明人 |
ANTON MAYR |
分类号 |
A61K35/76;C12N15/09;A61K39/275;A61K39/285;A61K39/39;A61K48/00;A61P31/20;C12N5/02;C12N5/10;C12N7/00;C12N7/01;C12N7/02;C12N7/08;C12N15/863;C12P21/02 |
主分类号 |
A61K35/76 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|